{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:10:45Z","timestamp":1782400245391,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Haemorrhoidal disease\u00a0(HD) is a common condition with significant epidemiologic and economic implications. While it is possible to treat symptomatic grade 1\u20132 haemorrhoids with rubber band ligation\u00a0(RBL) or sclerotherapy\u00a0(SCL), the effectiveness of these treatments compatible with current standards has not yet been investigated with a randomised controlled trial. The hypothesis is that SCL is not inferior to RBL in terms of symptom reduction (patient-related outcome measures (PROMs)), patient experience, complications or recurrence rate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and analysis<\/jats:title>\n                <jats:p>This protocol describes the methodology of a non-inferiority, multicentre, randomised controlled trial comparing rubber band ligation and sclerotherapy for symptomatic grade 1\u20132 haemorrhoids in adults (&gt;\u200918\u00a0years). Patients are preferably randomised between the two treatment arms. However, patients with a strong preference for one of the treatments and refuse randomisation are eligible for the registration arm. Patients either receive 4\u00a0cc Aethoxysklerol 3% SCL or 3\u2009\u00d7\u2009RBL. The primary outcome measures are symptom reduction by means of PROMs, recurrence and complication rates. Secondary outcome measures are patient experience, number of treatments and days of sick leave from work. Data are collected at 4 different time points.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The THROS trial is the first large multicentre randomised trial to study the difference in effectivity between RBL and SCL for the treatment of grade 1\u20132 HD. It will provide information as to which treatment method (RBL or SCL) is the most effective, gives fewer complications and is experienced by the patient as the best option.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ethics and dissemination<\/jats:title>\n                <jats:p>The study protocol has been approved by the Medical Ethics Review Committee of the Amsterdam University Medical Centers, location AMC (nr. 2020_053). The gathered data and results will be submitted for publication in peer-reviewed journals and spread to coloproctological associations and guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Dutch Trial Register <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/trialregister.nl\/trial\/8377\">NL8377<\/jats:ext-link>. Registered on 12\u201302-2020.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07400-2","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T12:02:09Z","timestamp":1685793729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of haemorrhoids: rubber band ligation or sclerotherapy (THROS)? Study protocol for a multicentre, non-inferiority, randomised controlled trial"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2835-3997","authenticated-orcid":false,"given":"J. Y.","family":"van Oostendorp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5913-2644","authenticated-orcid":false,"given":"T. C.","family":"Sluckin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5058-0574","authenticated-orcid":false,"given":"I. J. M.","family":"Han-Geurts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3084-0495","authenticated-orcid":false,"given":"S.","family":"van Dieren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-6868","authenticated-orcid":false,"given":"R.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the THROS trial research group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,3]]},"reference":[{"key":"7400_CR1","doi-asserted-by":"publisher","unstructured":"Margetis N. Pathophysiology of internal hemorrhoids. Ann Gastroenterol. 2019;32(3):264\u201372.\u00a0https:\/\/doi.org\/10.20524\/aog.2019.0355.","DOI":"10.20524\/aog.2019.0355"},{"key":"7400_CR2","doi-asserted-by":"publisher","unstructured":"Johanson JF, Sonnenberg A. The prevalence of hemorrhoids and chronic constipation. An epidemiologic study. Gastroenterol. 1990;98(2):380\u20136.\u00a0https:\/\/doi.org\/10.1016\/0016-5085(90)90828-o.","DOI":"10.1016\/0016-5085(90)90828-o"},{"issue":"11 Suppl","key":"7400_CR3","first-page":"2627","volume":"50","author":"JC Goligher","year":"1982","unstructured":"Goligher JC. Current trends in the use of sphincter-saving excision in the treatment of carcinoma of the rectum. Cancer. 1982;50(11 Suppl):2627\u201330.","journal-title":"Cancer"},{"key":"7400_CR4","doi-asserted-by":"publisher","unstructured":"van Tol RR, Kleijnen J, Watson AJM, Jongen J, Altomare DF, Qvist N, et al. European Society of ColoProctology: guideline for haemorrhoidal disease. Colorectal Dis. 2020;22(6):650\u201362.\u00a0https:\/\/doi.org\/10.1111\/codi.14975.","DOI":"10.1111\/codi.14975"},{"key":"7400_CR5","doi-asserted-by":"publisher","unstructured":"Madoff RD, Fleshman JW. American Gastroenterological Association technical review on the diagnosis and treatment of hemorrhoids. Gastroenterol. 2004;126(5):1463\u201373.\u00a0https:\/\/doi.org\/10.1053\/j.gastro.2004.03.008.","DOI":"10.1053\/j.gastro.2004.03.008"},{"key":"7400_CR6","doi-asserted-by":"publisher","unstructured":"Cocorullo G, Tutino R, Falco N, Licari L, Orlando G, Fontana T, et al. The non-surgical management for hemorrhoidal disease. A systematic review. G Chir. 2017;38(1):5\u201314.\u00a0https:\/\/doi.org\/10.11138\/gchir\/2017.38.1.005.","DOI":"10.11138\/gchir\/2017.38.1.005"},{"key":"7400_CR7","doi-asserted-by":"publisher","unstructured":"Sun Z, Migaly J. Review of Hemorrhoid Disease: Presentation and Management. Clin Colon Rectal Surg. 2016;29(1):22\u20139.\u00a0https:\/\/doi.org\/10.1055\/s-0035-1568144.","DOI":"10.1055\/s-0035-1568144"},{"key":"7400_CR8","doi-asserted-by":"publisher","unstructured":"Song SG, Kim SH. Optimal treatment of symptomatic hemorrhoids. J Korean Soc Coloproctol. 2011;27(6):277\u201381.\u00a0https:\/\/doi.org\/10.3393\/jksc.2011.27.6.277.","DOI":"10.3393\/jksc.2011.27.6.277"},{"key":"7400_CR9","first-page":"73","volume":"17","author":"L Akerud","year":"1995","unstructured":"Akerud L. Sclerotherapy of haemorrhoids. A prospective randomised trial of polidocanol and phenol in oil. Coloproctology. 1995;17:73\u201386.","journal-title":"Coloproctology"},{"key":"7400_CR10","doi-asserted-by":"publisher","unstructured":"van Tol RR, van Zwietering E, Kleijnen J, Melenhorst J, Stassen LPS, Dirksen CD, et al. Towards a core outcome set for hemorrhoidal disease-a systematic review of outcomes reported in literature. Int J Colorectal Dis. 2018;33(7):849\u201356.\u00a0https:\/\/doi.org\/10.1007\/s00384-018-3046-2.","DOI":"10.1007\/s00384-018-3046-2"},{"key":"7400_CR11","doi-asserted-by":"publisher","unstructured":"van Tol RR, Kimman ML, Melenhorst J, Stassen LPS, Dirksen CD, Breukink SO. European Society of Coloproctology Core Outcome Set for haemorrhoidal disease: an international Delphi study among healthcare professionals. Colorectal Dis. 2019;21(5):570\u201380.\u00a0https:\/\/doi.org\/10.1111\/codi.14553.","DOI":"10.1111\/codi.14553"},{"key":"7400_CR12","doi-asserted-by":"publisher","unstructured":"Chan A-W, Tetzlaff JM, Altman DG, et al. Spirit 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200\u20137.\u00a0https:\/\/doi.org\/10.7326\/0003-4819-158-3-201302050-00583.","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"7400_CR13","doi-asserted-by":"publisher","unstructured":"Kuiper SZ, Kimman ML, Van Tol RR, Waardenburg SF, Van Kuijk SMJ, Dirksen CD, Breukink SO. Patient reported outcome measure-haemorrhoidal impact and satisfaction score (PROM-HISS): Development, reliability and construct validity. Colorectal Dis. 2022. https:\/\/doi.org\/10.1111\/codi.16079. Epub ahead of print. PMID: 35119715.","DOI":"10.1111\/codi.16079"},{"key":"7400_CR14","doi-asserted-by":"publisher","first-page":"e046836","DOI":"10.1136\/bmjopen-2020-046836","volume":"11","author":"L Dekker","year":"2021","unstructured":"Dekker L, Han-Geurts IJM, van Dieren S, et al. HollAND trial: comparison of rubber band ligation and haemorrhoidectomy in patients with symptomatic haemorrhoids grade III: study protocol for a multicentre, randomised controlled trial and cost\u2013utility analysis. BMJ Open. 2021;11:e046836. https:\/\/doi.org\/10.1136\/bmjopen-2020-046836.","journal-title":"BMJ Open"},{"key":"7400_CR15","doi-asserted-by":"publisher","first-page":"106177","DOI":"10.1016\/j.cct.2020.106177","volume":"99","author":"SZ Kuiper","year":"2020","unstructured":"Kuiper SZ, Dirksen CD, Kimman ML, Van Kuijk SMJ, Van Tol RR, Muris JWM, Watson AJM, Maessen JMC, Melenhorst J, Breukink SO, Napoleon Trial Study Group. Effectiveness and cost-effectiveness of rubber band ligation versus sutured mucopexy versus haemorrhoidectomy in patients with recurrent haemorrhoidal disease (Napoleon trial): Study protocol for a multicentre randomized controlled trial. Contemp Clin Trials. 2020;99:106177. https:\/\/doi.org\/10.1016\/j.cct.2020.106177. Epub 2020 Oct 17. PMID: 33080380.","journal-title":"Contemp Clin Trials"},{"issue":"6","key":"7400_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10151-021-02430-x","volume":"25","author":"L Dekker","year":"2021","unstructured":"Dekker L, Han-Geurts IJM, R\u00f8rvik HD, van Dieren S, Bemelman WA. Rubber band ligation versus haemorrhoidectomy for the treatment of grade II-III haemorrhoids: a systematic review and meta-analysis of randomised controlled trials. Tech Coloproctol. 2021;25(6):663\u201374. https:\/\/doi.org\/10.1007\/s10151-021-02430-x. Epub 2021 Mar 8. PMID: 33683503; PMCID: PMC8124052.","journal-title":"Tech Coloproctol"},{"issue":"88","key":"7400_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20880","volume":"20","author":"S Brown","year":"2016","unstructured":"Brown S, Tiernan J, Biggs K, Hind D, Shephard N, Bradburn M, Wailoo A, Alshreef A, Swaby L, Watson A, Radley S, Jones O, Skaife P, Agarwal A, Giordano P, Lamah M, Cartmell M, Davies J, Faiz O, Nugent K, Clarke A, MacDonald A, Conaghan P, Ziprin P, Makhija R. The HubBLe Trial: haemorrhoidal artery ligation (HAL) versus rubber band ligation (RBL) for symptomatic second- and third-degree haemorrhoids: a multicentre randomised controlled trial and health-economic evaluation. Health Technol Assess. 2016;20(88):1\u2013150. https:\/\/doi.org\/10.3310\/hta20880. PMID:27921992;PMCID:PMC5165280.","journal-title":"Health Technol Assess"},{"key":"7400_CR18","doi-asserted-by":"publisher","unstructured":"Tan VZZ, Peck EW, Sivarajah SS, Tan WJ, Ho LML, Ng JL, Chong C, Aw D, Mainza F, Foo FJ, Koh FH. Systematic review and meta-analysis of postoperative pain and symptoms control following laser haemorrhoidoplasty versus Milligan-Morgan haemorrhoidectomy for symptomatic haemorrhoids: a new standard. Int J Colorectal Dis. 2022. https:\/\/doi.org\/10.1007\/s00384-022-04225-4. Epub ahead of print. PMID: 35906356.","DOI":"10.1007\/s00384-022-04225-4"},{"issue":"4","key":"7400_CR19","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1007\/s00268-020-05923-2","volume":"45","author":"K Lakmal","year":"2021","unstructured":"Lakmal K, Basnayake O, Jayarajah U, Samarasekera DN. Clinical outcomes and effectiveness of laser treatment for hemorrhoids: a systematic review. World J Surg. 2021;45(4):1222\u201336. https:\/\/doi.org\/10.1007\/s00268-020-05923-2. Epub 2021 Jan 19 PMID: 33469736.","journal-title":"World J Surg"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07400-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07400-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07400-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T12:02:36Z","timestamp":1685793756000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07400-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,3]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7400"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07400-2","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,3]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Received on 29\u201309-2020 from the Medical Ethics board of Amsterdam Medical Center, Amsterdam, the Netherlands (nr. 2020_053).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"374"}}